Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
1-Methylpiperazine prices in Germany, the highest-cost reporting region, rose 2.9% in Q2 2026 to USD 8,950.00/MT from USD 8,700.00/MT in Q1, extending a sharp reversal from the gradual multi-quarter decline that had characterized this market through most of 2025. Globally, the average rose from USD 7,384.00/MT in Q1 to USD 7,600.00/MT in Q2, a 2.9% gain, following a jump of 10.0% in Q1 alone as elevated piperazine and methylating agent feedstock costs reversed the earlier softening trend. For H2 2026, a global average of USD 6,300.00-9,150.00/MT is expected, with elevated feedstock costs likely to keep this market firm.
1-Methylpiperazine is a cyclic organic amine produced through the methylation of piperazine, serving as a critical building block intermediate in pharmaceutical synthesis, most notably in the production of fluoroquinolone antibiotics including ciprofloxacin and related compounds, alongside use in agrochemical intermediate synthesis and specialty chemical manufacturing. Downstream demand spans antibiotic active pharmaceutical ingredient production, agrochemical formulation, and dye and pigment intermediate applications. Because piperazine itself is derived from ethylenediamine and related nitrogen chemistry, and methylation typically relies on methanol or formaldehyde as the methylating agent, this market's cost structure tracks multiple nitrogen and petrochemical feedstock chains simultaneously. Piperazine and methylating agent feedstock costs, pharmaceutical antibiotic synthesis demand, and regional production capacity utilization are what drive prices in this market.
The outlook for 1-Methylpiperazine through H2 2026 stays firm, tracking elevated piperazine and methylating agent feedstock costs tied to the broader Strait of Hormuz-linked petrochemical cost environment. Steady demand from fluoroquinolone antibiotic manufacturers, alongside continued agrochemical intermediate consumption, should continue supporting consumption even as the pace of further gains likely moderates from the sharp Q1 2026 spike that characterized every region covered here.
The main upside risk is a further tightening of piperazine or methylating agent feedstock availability, which would push production costs higher across every region. The main downside risk is a faster-than-expected normalization of feedstock costs combined with softer antibiotic and agrochemical demand, which would ease some of the current price pressure.
| Region | 2026 Price Range (USD/MT) | Outlook |
| Global Average | 6,300.00 - 9,150.00 | Elevated feedstock costs keep this market firm |
| Germany | 8,300.00 - 9,700.00 | Established pharmaceutical intermediate base sustains the highest cost |
| United States | 7,500.00 - 8,800.00 | Steady antibiotic synthesis demand supports continued firmness |
| India | 6,300.00 - 7,400.00 | Growing generic API demand drives continued gains |
| China | 5,600.00 - 6,550.00 | Large-scale production capacity keeps this the most affordable market |
German 1-Methylpiperazine prices averaged USD 8,950.00/MT in Q2 2026, the highest of any region tracked here, up 2.9% from USD 8,700.00/MT in Q1, as this market's established pharmaceutical intermediate base continued sustaining the premium.
Why did the price of 1-Methylpiperazine change in Q2 2026 in Germany?
Elevated piperazine and methylating agent feedstock costs continued flowing through to finished 1-methylpiperazine pricing, while steady demand from European pharmaceutical intermediate manufacturers kept this market at the top of the range tracked in this report.
US prices averaged USD 8,150.00/MT in Q2 2026, up 3.2% from USD 7,900.00/MT in Q1, as steady fluoroquinolone antibiotic synthesis demand continued driving gains.
Why did the price of 1-Methylpiperazine change in Q2 2026 in the United States?
Steady demand from fluoroquinolone antibiotic manufacturers, including ciprofloxacin producers, kept US buyers active even as feedstock costs continued moving higher through the quarter.
Indian prices averaged USD 6,850.00/MT in Q2 2026, up 3.0% from USD 6,650.00/MT in Q1, as growing generic API manufacturing demand continued supporting this market.
Why did the price of 1-Methylpiperazine change in Q2 2026 in India?
Continued growth in demand from India's expanding generic pharmaceutical API manufacturing sector kept buyers competing for available supply.
Chinese prices, the lowest of the four regions, averaged USD 6,050.00/MT in Q2 2026, up 2.5% from USD 5,900.00/MT in Q1, as large-scale domestic production capacity continued absorbing elevated feedstock costs.
Why did the price of 1-Methylpiperazine change in Q2 2026 in China?
Large-scale domestic production capacity continued keeping Chinese offers the most competitive of any region tracked here, even as the broader piperazine feedstock cost environment pushed prices modestly higher.
German prices surged 10.1% in Q1 2026 to USD 8,700.00/MT from USD 7,900.00/MT in Q4 2025, as piperazine and methylating agent feedstock costs spiked following the broader Middle East-linked energy market disruption.
Why did the price of 1-Methylpiperazine change in Q1 2026 in Germany?
Piperazine and methylating agent prices surged sharply as the global feedstock repricing following Middle East escalation raised the cost basis across the entire fluoroquinolone intermediate value chain, and that pressure flowed directly through to finished 1-methylpiperazine pricing across German pharmaceutical supply chains.
US prices surged 9.7% in Q1 2026 to USD 7,900.00/MT from USD 7,200.00/MT in Q4 2025, tracking the broader feedstock cost spike.
Why did the price of 1-Methylpiperazine change in Q1 2026 in the United States?
Elevated piperazine and methylating agent feedstock costs, tied to the Middle East-linked energy market disruption, pushed US production expenses sharply higher, even as steady underlying antibiotic synthesis demand kept this market fundamentally well supported.
Indian prices surged 9.9% in Q1 2026 to USD 6,650.00/MT from USD 6,050.00/MT in Q4 2025, tracking the broader Asian feedstock cost spike.
Why did the price of 1-Methylpiperazine change in Q1 2026 in India?
Elevated crude oil and natural gas prices, following disruptions to global energy markets tied to the Middle East conflict, increased production costs for piperazine feedstock, pushing Indian 1-methylpiperazine prices higher through the quarter.
Chinese prices surged 10.3% in Q1 2026 to USD 5,900.00/MT from USD 5,350.00/MT in Q4 2025, tracking the global piperazine feedstock cost spike even as domestic production capacity remained substantial.
Why did the price of 1-Methylpiperazine change in Q1 2026 in China?
Rising piperazine and methylating agent feedstock costs, tied to the broader Middle East-linked petrochemical cost environment, fed through to Chinese 1-methylpiperazine pricing even as the country's substantial domestic production capacity kept the pace of the increase comparatively moderate.
Global 1-Methylpiperazine prices eased gradually through most of 2025 as piperazine feedstock costs moderated, before accelerating sharply in Q1 2026 as rising piperazine and methylating agent feedstock costs, tied to the broader Middle East-linked energy market disruption, pushed prices to their highest levels of the period, a trend that continued into Q2 across every region tracked in this report.
| Quarter | Price (USD/MT) | QoQ Change | Direction |
| Q2 2026 | 7,600.00 | +2.9% | ↑ Rising |
| Q1 2026 | 7,384.00 | +10.0% | ↑ Rising |
| Q4 2025 | 6,713.00 | -2.6% | ↓ Falling |
| Q3 2025 | 6,890.00 | -2.5% | ↓ Falling |
| Q2 2025 | 7,067.00 | - | — Stable |
| Q3 2026 | In Progress | - | — In Progress |
1-Methylpiperazine eased across every market covered in this report through 2025, tracking moderating piperazine and methylating agent feedstock costs, before the Middle East-linked energy market disruption sharply reversed that trend in Q1 2026, pushing feedstock costs, and with them fluoroquinolone intermediate production economics, higher across every region tracked here.
German prices eased from about USD 8,500.00/MT in Q1 2025 to USD 7,900.00/MT by Q4, down roughly 7.1%, before the sharp Q1 2026 reversal that followed.
US prices eased from about USD 7,800.00/MT in Q1 2025 to USD 7,200.00/MT by Q4, down roughly 7.7%, the steepest annual decline of the four regions.
Indian prices eased from about USD 6,500.00/MT in Q1 2025 to USD 6,050.00/MT by Q4, down roughly 6.9%, tracking the broader moderating feedstock cost trend.
Chinese prices eased from about USD 5,800.00/MT in Q1 2025 to USD 5,350.00/MT by Q4, down roughly 7.8%, the largest annual decline of the four regions, before the sharp reversal that followed once feedstock costs spiked.
Expert Market Research: Your Source for Real-Time 1-Methylpiperazine Price Intelligence
Expert Market Research tracks 1-Methylpiperazine prices continuously across every major producing and consuming region, combining piperazine and methylating agent feedstock cost data, pharmaceutical antibiotic synthesis demand signals, and regional production capacity utilization trends into a single, regularly updated view of the market. Our team can help your procurement function benchmark current offers, plan purchases around the sharp reversal covered in this report, and build a defensible view of where this essential pharmaceutical intermediate is headed next. Reach out to our team for a tailored briefing or a deeper look at any of the regional markets covered here.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
It serves as a critical building block intermediate in pharmaceutical synthesis, most notably in the production of fluoroquinolone antibiotics including ciprofloxacin and related compounds, alongside use in agrochemical intermediate synthesis and specialty chemical manufacturing.
The Q2 2026 global average was USD 7,600.00/MT, ranging from USD 6,050.00/MT in China to USD 8,950.00/MT in Germany.
The global average rose from USD 6,713.00/MT in Q4 2025 to USD 7,384.00/MT in Q1 2026, a 10.0% jump, and then to USD 7,600.00/MT in Q2, tracking elevated piperazine and methylating agent feedstock costs.
Piperazine and methylating agent prices surged sharply as the global feedstock repricing following Middle East escalation raised the cost basis across the entire fluoroquinolone antibiotic intermediate value chain, reversing the gradual softening trend recorded through most of 2025.
The global average is expected in the USD 6,300.00-9,150.00/MT range, with elevated feedstock costs likely to keep this market firm.
China holds the lowest cost given large-scale production capacity, while Germany carries the highest cost among the regions tracked here given its established pharmaceutical intermediate base.
This report is updated monthly. For real-time pricing intelligence, connect with the Expert Market Research team.
Piperazine and methylating agent feedstock costs, pharmaceutical antibiotic synthesis demand, and regional production capacity utilization.
China maintains substantial production capacity, with Germany, the United States, and India also significant producing and consuming markets tied to their domestic pharmaceutical antibiotic manufacturing industries.
Buyers can monitor piperazine and methylating agent feedstock cost trends given their outsized influence on this market, time forward purchases around the quarterly breakdowns in this report, and benchmark supplier quotes against the tracked price ranges.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.